STOCK TITAN
  1. Home
  2. Sec-filings
  3. ACOG
  4. [EFFECT] Alpha Cognition Inc. SEC Filing

[EFFECT] Alpha Cognition Inc. SEC Filing

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
EFFECT
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: July 8, 2025 4:00 P.M.
Form: S-3
CIK: 0001655923
Company Name: Alpha Cognition Inc.
File Number: 333-288454

Source: View Original Filing on SEC EDGAR

Alpha Cognition

NASDAQ:ACOG

View ACOG Stock Overview →

ACOG Rankings

#4884 Ranked by Market Cap
N/A Ranked by Dividends

ACOG Latest News

Mar 13, 2026
Alpha Cognition (Nasdaq: ACOG) to Report Fourth Quarter and Full Year 2025 Financial Results and Provide Business Update on Thursday, March 26, 2026
Mar 10, 2026
Alpha Cognition to Present New Clinical on ZUNVEYL® (Benzgalantamine) at Multiple Upcoming Alzheimer’s Association International Conferences
Feb 25, 2026
Alpha Cognition Announces First Patient Enrolled in BEACON Real-World Effectiveness Study
Feb 18, 2026
Alpha Cognition Announces Issuance of Additional U.S. Patent Covering ZUNVEYL ® Dosing Regimens
Jan 7, 2026
Alpha Cognition Provides 2026 Corporate Update Highlighting Strategic Priorities and 2025 Commercial Execution

ACOG Latest SEC Filings

Mar 20, 2026
[Form 4] Alpha Cognition Inc. Insider Trading Activity
Mar 18, 2026
[Form 4] Alpha Cognition Inc. Insider Trading Activity
Mar 13, 2026
[Form 4] Alpha Cognition Inc. Insider Trading Activity
Mar 10, 2026
[Form 4] Alpha Cognition Inc. Insider Trading Activity
Mar 6, 2026
[Form 4] Alpha Cognition Inc. Insider Trading Activity

ACOG Stock Data

124.15M
19.25M
Biotechnology
Biological Products, (no Diagnostic Substances)
Link
Canada
VANCOUVER